1Nori D, Moni FJ. Current issues in techniques of prostate brachytherapy[J]. Semin Surg Oncol, 1997, 13: 444-453.
2Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997[J]. CA J Clin, 1997, 47: 5-27.
3Vicini FA, Horwitz EM, Gonzalez J, et al. Treatment options for localized prostate cancer based upon pretreatment prostate specific antigen levels[J]. J Urol, 1997, 158: 319-325.
4Vicini FA, Horwitz EM, Kini VR, et al. Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate specific antigen levels and biochemical control: A comprehensive review of the literature[J]. Int J Radiat Oncol Biol Phys, 1998, 40:1101-1110.
5Horwitz EM, Vicini FA, Ziaja EL, et al. Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of bioeheroieal control [J]. Int J Radiat Oncol Biol Phys, 1996, 36: 565-575.
6Hilaris RS. Brachytherapy in cancer of the prostate: an historical perspective[J]. Semin Surg Oncol, 1997, 13: 399-405.
7Vicini FA, Kini VR, Edmundson G, et al. A comprehensive review of prostate cancer brachytherapy: difining an optimal technique[J]. Int J Radiat Oncol Biol Phys, 1999, 44: 483-491.
8Blasko JC, Wallner K, Grimm PD, et al. Prostate specific antigen based disease control following ultrasound guided 125-iodine implantation for stage T1/T2 prostatic carcinoma[J]. J Urol, 1995, 154: 1096-1099.
9Mate TP, Gottesman JE, Hatton J, et al. High dose-rate afterloading 192-iridium prostate brachytherapy: Feasibility report [J]. Int J Radiat Oncol Biol Phys, 1998, 41: 525-533.
10Wallner K, Roy J, Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma[J]. J Clin Oncol, 1996, 14: 449-453.
3Whitmore WFJ, Hilaris B, Grabstald H. Retropubie implant ation of iodine 125 in the treatment of prostatic cancer[J].J Urol,1972, 108:918.
4Holm HH,Northeved A. An ultrasonic scanning apparatus for use in medical diagnosis[J]. Acta Chir Scand, 1986,134 : 177.
5Hilaris RS. Brachytherapy in cancer of the prostate: A historical pets pective[J]. Semin Surg Oncol, 1997,13 : 399 - 4051.
6Sharkey J, Cantor A, Solc Z, et al. 103pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: A 12 - year experience from a single group practice[J].Brachytherapy, 2005, 4:34 - 44.
8Sherertz T,Wallner K,Merrick G,et al. Factors p redictive of rectal bleeding after 103pd and supp lemental beam radiation for p rostate cancer [J]. Brachytherapy, 2004,3 : 130 - 135.
10Ramos CG, Carvalhal GF, Smith DS, et al. Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer [J]. J Urol, 1999, 161(4) :1212-1215.
